2024, Vol 14, No. 6

Editor-in-Chief

Prof. Khosro Adibkia

Editorial

1. Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignancies

Jaleh Barar* , Yadollah Omidi*

Bioimpacts. 2015;5(2): 65-69. doi: 10.15171/bi.2015.18

PMCID: PMC4492186 PMID: 26191499 Scopus ID: 84930410369

Article

PDF

XML

Cited By:

Editorial

2. Made-on-demand, complex and personalized 3D-printed drug products

Karim Osouli-Bostanabad, Khosro Adibkia*

Bioimpacts. 2018;8(2): 77-79. doi: 10.15171/bi.2018.09

PMCID: PMC6026524 PMID: 29977828 Scopus ID: 85048089691

Article

PDF

Full Text

XML

Cited By:

Editorial

3. Aptamedicine: a new treatment modality in personalized cancer therapy

Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar , Yadollah Omidi*

Bioimpacts. 2019;9(2): 67-70. doi: 10.15171/bi.2019.09

PMCID: PMC6637218 PMID: 31334037 Scopus ID: 85067455587

Article

PDF

Full Text

XML

Cited By:

Aptamers (Aps) are short single-strand nucleic acids, which can be used as the therapeutic and targeting agent in advanced drug delivery systems. Conjugation of Aps with other entities (siRNA, toxins, drugs, DNAzyme/Ribozymes) provides advanced multifunctional nanosystems for cancer therapy.

Review

4. Regulation of cell fate by cell imprinting approach in vitro

Farkhonde Hasannejad , Leila Montazeri, João F Mano* , Shahin Bonakdar* , Ahmad ‎ Fazilat

Bioimpacts. 2024;14(3): 29945. doi: 10.34172/bi.2023.29945

PMCID: PMC11199935 PMID: 38938752

Article

PDF

XML

Cited By:

Review

5. Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologies

Sepideh Parvizpour* , Hanieh Beyrampour-Basmenj, Jafar Razmara* , Farhad Farhadi, Mohd Shahir Shamsir

Bioimpacts. 2024;14(4): 29957. doi: 10.34172/bi.2023.29957

PMCID: PMC11298019 PMID: 39104623

Article

PDF

Full Text

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons